2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]-
概述 用途與合成方法 MSDS 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]-價(jià)格(試劑級) 上下游產(chǎn)品信息
| 中文名稱 | 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- |
|---|---|
| 中文同義詞 | 福西非丹西替尼;化合物FOSIFIDANCITINIB;(5-((2-((4-氟-3-甲氧基-5-甲基苯基)氨基)-5-甲基嘧啶-4-基)氨基)-2-氧代苯并[D]惡唑-3(2H)-基)甲基磷酸酯 |
| 英文名稱 | 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- |
| 英文同義詞 | 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]-;Janus kinase,JAK,Inhibitor,Fosifidancitinib,inhibit;5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl dihydrogen phosphate;(5-((2-((4-Fluoro-3-methoxy-5-methylphenyl)amino)-5-methylpyrimidin-4-yl)amino)-2-oxobenzo[d]oxazol-3(2H)-yl)methyl dihydrogen phosphate;{[5-({2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methylpyrimidin-4-yl}amino)-2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl]methoxy}phosphonic acid;Fosifidancitinib |
| CAS號 | 1237168-58-9 |
| 分子式 | C21H21FN5O7P |
| 分子量 | 505.39 |
| EINECS號 | |
| 相關(guān)類別 | |
| Mol文件 | 1237168-58-9.mol |
| 結(jié)構(gòu)式 | ![2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- 結(jié)構(gòu)式](CAS/20210305/GIF/1237168-58-9.gif) |
2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- 性質(zhì)
| 沸點(diǎn) | 761.3±70.0 °C(Predicted) |
|---|---|
| 密度 | 1.564±0.06 g/cm3(Predicted) |
| 酸度系數(shù)(pKa) | 1.75±0.10(Predicted) |
2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- 用途與合成方法
Fosifidancitinib 是一種JAK激酶 1/3 的有效選擇性抑制劑。Fosifidancitinib 用于過敏、哮喘和自身免疫性疾病的研究。
安全信息
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價(jià)格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-109175 | Fosifidancitinib | 1237168-58-9 | 1 mg | 2210元 |